Cyllene Therapeutics
PrivateLast Round
Series C
Jul 7, 2026
Total Funding Raised
$85.96M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Cyllene Therapeutics is a biotechnology company that develops non-replicating HSV-1 vector technology for neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cyllene Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Cyllene Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 7, 2026 | ||||
| Series B | Feb 20, 2025 | ||||
| Series A Extension | Jul 13, 2023 | ||||
| Series A | Mar 1, 2021 |
Cyllene Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SCI Ventures | Series B |
| GordonMD Global Investments | Series C |
| Andera Partners | Series C, Series B |
| M Ventures | Series C |
| Bpifrance | Series B |
| Bpifrance Investissement | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 7, 2026
$38M round led by GordonMD Global Investments and M Ventures.
- Feb 20, 2025
$28M round led by Andera Partners and Bpifrance.
Cyllene Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cyllene Therapeutics's valuation, stock price, and market status.